Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Icaritin - Shenogen Pharma

Drug Profile

Icaritin - Shenogen Pharma

Alternative Names: IC-162; SNG 162

Latest Information Update: 20 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shenogen Pharma
  • Developer Chinese Academy of Medical Sciences; Shenogen Pharma
  • Class Antineoplastics; Benzopyrans; Flavonoids; Phenyl ethers; Small molecules
  • Mechanism of Action Estrogen receptor alpha modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Liver cancer
  • Discontinued Breast cancer; Solid tumours

Most Recent Events

  • 13 Feb 2025 Sir Run Run Shaw Hospital plans a phase III trial for Pancreatic ductal carcinoma (Late-stage disease, Metastatic disease, First-line therapy), in China (PO, Capsule), in March 2025 (NCT06825546)
  • 20 Jun 2023 Shenogen Pharma in collaboration with Zhejiang Cancer Hospital plans a phase II trial for Liver cancer(Combination therapy) (PO, Capsule) (NCT05903456)
  • 25 May 2023 Chemical structure information added

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top